You just read:

Study Documents Biopharmaceutical Industry's Increased Investment in Personalized Cancer Treatments, Including Immunotherapies, Underlining Importance of Reimbursement Policies That Facilitate Sustainable Access

News provided by

Personalized Medicine Coalition

Oct 30, 2019, 08:40 ET